# Trial of Hydroxychloroquine In Covid-19 Kinetics

> **NCT04353271** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of South Alabama** · enrollment: 3 (actual)

## Conditions studied

- Covid 19
- Corona Virus Infection

## Interventions

- **DRUG:** Hydroxychloroquine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04353271
- **Lead sponsor:** University of South Alabama
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-04-17
- **Primary completion:** 2020-07-08
- **Final completion:** 2020-07-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** FDA recommendations to not use outside of the hospital setting or in a clinical trial due to the risk of cardiac arrhythmias
- **Last updated:** 2022-01-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04353271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04353271, "Trial of Hydroxychloroquine In Covid-19 Kinetics". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04353271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*